Andy Livingston, MD, MS (he/him/his)
Associate Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Gregory M. Cote, MD, PhD (he/him/his)
Assistant Professor
Mass General Cancer Center
Boston, Massachusetts, United States
Jean-Yves Blay, MD, PhD
PUPH
Centre Léon-Bérard
Lyon, Rhone-Alpes, France
Jonathan Trent, MD, PhD
Professor of Medicine
Sylvester Comprehensive Cancer Center, University of Miami
Miami, Florida, United States
Claudia Valverde, MD
Senior Consultant Medical Oncology Department
Vall D’Hebron University Hospital
Barcelona, Catalonia, Spain
Mark Agulnik, MD (he/him/his)
Sarcoma Section Chief
City of Hope, Department of Medical Oncology & Therapeutics Research
Duarte, California, United States
Mrinal Gounder, MD
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Axel Le Cesne, MD
Gustave Roussy Institute
Villejuif, Ile-de-France, France
Meredith McKean, MPH, MD
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Michael J. Wagner, MD
University of Washington/Fred Hutch/Seattle Cancer Care Alliance
Seattle, Washington, United States
Silvia Stacchiotti, MD (she/her/hers)
Consultant
Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Milano, Lombardia, Italy
Samuel V. Agresta, MD
Chief Medical Officer
Foghorn Therapeutics
Lexington, Massachusetts, United States
Sarah Reilly, MD, MPH
Senior Medical Director
Foghorn Therapeutics
Boston, Massachusetts, United States
Kathleen Healy, n/a
Foghorn Therapeutics
Cambridge, Massachusetts, United States
Denice Hickman, Registered Nurse/BSN (she/her/hers)
Senior Director, Pharmacovigilance and Safety
Foghorn Therapeutics
Cambridge, Massachusetts, United States
Mike Collins, PhD (he/him/his)
Senior Scientist, Translational Research
Foghorn Therapeutics
Cambridge, Massachusetts, United States
Scott Innis, MS
VP, Program Lead
Foghorn Therapeutics
Cambridge, Massachusetts, United States
Alexandra R. Ballesteros-Perez, PhD (she/her/hers)
Associate Director, Clinical Pharmacologist
Certara
Richmond Hill, Georgia, United States
Andrew J. Wagner, MD, PhD
Associate Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
